1. Home
  2. ACIC vs HQL Comparison

ACIC vs HQL Comparison

Compare ACIC & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Coastal Insurance Corporation

ACIC

American Coastal Insurance Corporation

HOLD

Current Price

$11.37

Market Cap

538.1M

Sector

Finance

ML Signal

HOLD

Logo abrdn Life Sciences Investors Shares of Beneficial Interest

HQL

abrdn Life Sciences Investors Shares of Beneficial Interest

HOLD

Current Price

$16.26

Market Cap

490.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACIC
HQL
Founded
1999
1992
Country
United States
United States
Employees
68
N/A
Industry
Property-Casualty Insurers
Investment Managers
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
538.1M
490.5M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
ACIC
HQL
Price
$11.37
$16.26
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
244.0K
105.3K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
6.78%
11.56%
EPS Growth
39.61
N/A
EPS
2.15
0.79
Revenue
$335,439,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.00
N/A
P/E Ratio
$5.15
$20.54
Revenue Growth
13.07
N/A
52 Week Low
$9.97
$10.55
52 Week High
$13.06
$17.80

Technical Indicators

Market Signals
Indicator
ACIC
HQL
Relative Strength Index (RSI) 52.35 42.05
Support Level $10.97 $15.66
Resistance Level $11.85 $17.51
Average True Range (ATR) 0.27 0.31
MACD -0.02 -0.01
Stochastic Oscillator 54.23 41.27

Price Performance

Historical Comparison
ACIC
HQL

About ACIC American Coastal Insurance Corporation

American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.

Share on Social Networks: